71 related articles for article (PubMed ID: 19832725)
1. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin.
Ray ER; Chatterton K; Khan MS; Chandra A; Thomas K; Dasgupta P; O'Brien TS
BJU Int; 2010 Mar; 105(6):789-94. PubMed ID: 19832725
[TBL] [Abstract][Full Text] [Related]
2. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
Stenzl A; Burger M; Fradet Y; Mynderse LA; Soloway MS; Witjes JA; Kriegmair M; Karl A; Shen Y; Grossman HB
J Urol; 2010 Nov; 184(5):1907-13. PubMed ID: 20850152
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study.
Smith AB; Daneshmand S; Patel S; Pohar K; Trabulsi E; Woods M; Downs T; Huang W; Taylor J; Jones J; O'Donnell M; Bivalacqua T; DeCastro J; Steinberg G; Kamat A; Resnick M; Konety B; Schoenberg M; Jones JS; Lotan Y;
BJU Int; 2019 Jan; 123(1):35-41. PubMed ID: 29979488
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic application in diagnostic procedures and treatment of non-melanoma skin cancers.
Yang Z; Li D; Shi D
Curr Treat Options Oncol; 2024 May; 25(5):619-627. PubMed ID: 38581550
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic effects of fluorescence cystoscopy and narrow-band imaging in bladder cancer: a systematic review and network meta-analysis.
Fan Z; Shi H; Luo J; Guo X; Wang B; Liu Y; Yu J
Int J Surg; 2023 Oct; 109(10):3169-3177. PubMed ID: 37526087
[TBL] [Abstract][Full Text] [Related]
6. [Transurethral resection of bladder tumors (TURBT)].
Oswald D; Pallauf M; Herrmann TRW; Netsch C; Becker B; Lehrich K; Miernik A; Schöb DS; Sievert KD; Gross AJ; Westphal J; Lusuardi L; Deininger S
Urologe A; 2022 Jan; 61(1):71-82. PubMed ID: 34982181
[TBL] [Abstract][Full Text] [Related]
7. Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.
Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013776. PubMed ID: 34850382
[TBL] [Abstract][Full Text] [Related]
8. Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis.
Russo GI; Sholklapper TN; Cocci A; Broggi G; Caltabiano R; Smith AB; Lotan Y; Morgia G; Kamat AM; Witjes JA; Daneshmand S; Desai MM; Gill IS; Cacciamani GE
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503188
[TBL] [Abstract][Full Text] [Related]
9.
Grüne B; Rother J; Waldbillig F; Chellappan G; Meessen S; Grychtol B; Deliolanis NC; Bolenz C; Kriegmair MC
Transl Androl Urol; 2021 Jun; 10(6):2373-2383. PubMed ID: 34295724
[TBL] [Abstract][Full Text] [Related]
10. Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary?
Calò B; Sanguedolce F; Falagario UG; Chirico M; Fortunato F; Carvalho-Diaz E; Busetto GM; Bettocchi C; Carrieri G; Cormio L
World J Urol; 2021 Oct; 39(10):3815-3821. PubMed ID: 33830306
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer.
Chen C; Huang H; Zhao Y; Liu H; Luo Y; Sylvester RJ; Li JP; Lam TB; Lin T; Huang J
J Cancer; 2020; 11(5):1082-1093. PubMed ID: 31956355
[No Abstract] [Full Text] [Related]
12. Detection of carcinogen-induced bladder cancer by fluorocoxib A.
Bourn J; Rathore K; Donnell R; White W; Uddin MJ; Marnett L; Cekanova M
BMC Cancer; 2019 Nov; 19(1):1152. PubMed ID: 31775672
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
Chen C; Huang H; Zhao Y; Liu H; Sylvester R; Lin T; Huang J
BMJ Open; 2019 Oct; 9(10):e028173. PubMed ID: 31628123
[TBL] [Abstract][Full Text] [Related]
14. A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future 'MRI-PDD Fusion TURBT'.
Miyake M; Maesaka F; Marugami N; Miyamoto T; Nakai Y; Ohnishi S; Gotoh D; Owari T; Hori S; Morizawa Y; Itami Y; Inoue T; Anai S; Torimoto K; Fujii T; Shimada K; Tanaka N; Fujimoto K
Diagnostics (Basel); 2019 Sep; 9(3):. PubMed ID: 31487881
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical.
Pederzoli F; Murati Amador B; Samarska I; Lombardo KA; Kates M; Bivalacqua TJ; Matoso A
Hum Pathol; 2019 Aug; 90():1-7. PubMed ID: 31071342
[TBL] [Abstract][Full Text] [Related]
16. Potential Applications of Nanotechnology in Urological Cancer.
He MH; Chen L; Zheng T; Tu Y; He Q; Fu HL; Lin JC; Zhang W; Shu G; He L; Yuan ZX
Front Pharmacol; 2018; 9():745. PubMed ID: 30038573
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.
Kassouf W; Aprikian A; Black P; Kulkarni G; Izawa J; Eapen L; Fairey A; So A; North S; Rendon R; Sridhar SS; Alam T; Brimo F; Blais N; Booth C; Chin J; Chung P; Drachenberg D; Fradet Y; Jewett M; Moore R; Morash C; Shayegan B; Gotto G; Fleshner N; Saad F; Siemens DR
Can Urol Assoc J; 2016; 10(1-2):E46-80. PubMed ID: 26977213
[No Abstract] [Full Text] [Related]
18. CUA guidelines on the management of non-muscle invasive bladder cancer.
Kassouf W; Traboulsi SL; Kulkarni GS; Breau RH; Zlotta A; Fairey A; So A; Lacombe L; Rendon R; Aprikian AG; Siemens DR; Izawa JI; Black P
Can Urol Assoc J; 2015; 9(9-10):E690-704. PubMed ID: 26664503
[No Abstract] [Full Text] [Related]
19. Nanotechnology in bladder cancer: current state of development and clinical practice.
Tomlinson B; Lin TY; Dall'Era M; Pan CX
Nanomedicine (Lond); 2015; 10(7):1189-201. PubMed ID: 25929573
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer: Always consider extravesical sites when BCG fails.
von Rundstedt FC; Lerner SP
Nat Rev Urol; 2014 Jan; 11(1):11-2. PubMed ID: 24346003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
